These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2588933)

  • 1. Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type IA.
    Hauffa BP; Illig R; Torresani T; Stolecke H; Phillips JA
    Acta Endocrinol (Copenh); 1989 Nov; 121(5):609-14. PubMed ID: 2588933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated human growth hormone deficiency due to the hGH-I gene deletion with (type IA) and without (the Israeli-type) hGH antibody formation during hGH therapy.
    Nishi Y; Masuda H; Nishimura S; Kihara M; Suwa S; Tachibana K; Takeda M; Okada Y; Matsuda I
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):267-71. PubMed ID: 1969217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
    Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
    Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pituitary dwarfism with methionyl human growth hormone in Japan.
    Takano K; Shizume K; Hizuka N; Okuno A; Umino T; Kobayashi Y; Kusano S; Nakajima H; Irie M; Hibi I
    Endocrinol Jpn; 1986 Oct; 33(5):589-96. PubMed ID: 3830068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of growth attenuation during methionyl human growth hormone treatment.
    Okada Y; Taira K; Takano K; Hizuka N
    Endocrinol Jpn; 1987 Aug; 34(4):621-6. PubMed ID: 3678156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations.
    Mullis PE; Akinci A; Kanaka C; Eblé A; Brook CG
    Pediatr Res; 1992 May; 31(5):532-4. PubMed ID: 1603635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
    Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
    Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated growth hormone deficiency type 1A in a Japanese family.
    Nishi Y; Aihara K; Usui T; Phillips JA; Mallonee RL; Migeon CJ
    J Pediatr; 1984 Jun; 104(6):885-9. PubMed ID: 6539375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
    Grumbach MM; Bin-Abbas BS; Kaplan SL
    Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of idiopathic pituitary dwarfism with methionyl human growth hormone.
    Takano K; Shizume K; Hizuka N; Hibi I; Kato K; Kohno H; Kondo T; Ogawa M; Okada Y; Sudo M
    Endocrinol Jpn; 1983 Aug; 30(4):523-7. PubMed ID: 6671456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human growth hormone gene deletion without antibody formation or growth arrest during treatment--a new disease entity?
    Laron Z; Kelijman M; Pertzelan A; Keret R; Shoffner JM; Parks JS
    Isr J Med Sci; 1985 Dec; 21(12):999-1006. PubMed ID: 3005192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human pituitary growth hormone (hGH) therapy in growth hormone deficiency.
    Frasier SD
    Endocr Rev; 1983; 4(2):155-70. PubMed ID: 6345147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turner's syndrome: treatment of 203 patients with recombinant human growth hormone for one year. A multicentre study.
    Takano K; Shizume K; Hibi I
    Acta Endocrinol (Copenh); 1989 May; 120(5):559-68. PubMed ID: 2658450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
    Takano K; Hizuka N; Shizume K
    Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic heterogeneity in familial isolated growth hormone deficiency type I-A.
    Rivarola MA; Phillips JA; Migeon CJ; Heinrich JJ; Hjelle BJ
    J Clin Endocrinol Metab; 1984 Jul; 59(1):34-40. PubMed ID: 6327759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience with somatrem in growth hormone deficiency.
    Vicens-Calvet E; Potau N; Carracosa A; Albisu M; Gusiñer M; Cuatrecasas JM; Strindberg B; Flodh H
    Acta Paediatr Scand Suppl; 1986; 325():33-40. PubMed ID: 3296638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience of somatrem: UK preliminary report.
    Milner RD
    Acta Paediatr Scand Suppl; 1986; 325():25-8. PubMed ID: 3296636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of pituitary dwarfism with authentic recombinant human growth hormone (SM-9500).
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Endocrinol Jpn; 1987 Apr; 34(2):291-7. PubMed ID: 3622395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children.
    Kastrup KW; Christiansen JS; Andersen JK; Orskov H
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):148-52. PubMed ID: 6637329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.